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Abstract
The progress of the pharmacological and device treatment of heart failure (HF) has led to a substantial
improvement of mortality and rehospitalization. Further potential for improvement may be heralded in the
post-discharge management of HF patients, including patient education for self-management of HF. The study
by Musekamp et al. is among the first publications providing evidence that improvements in self-management
skills may improve outcomes of HF patients. It is concluded that multimodal approaches addressing comorbidities in
HF patients with novel concepts, and by optimal and specific HF management, including patient education, may
ultimately contribute to substantial improvement of HF prognosis.
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The article by Musekamp et al. [1] focuses on a hu-
manitarian and medical problem which is truly impres-
sive, namely, the self-management of heart failure (HF)
patients. It is an issue that shares some similitudes with
the self-management of diabetes mellitus. Albeit we are
lacking reliable laboratory parameters of the homeo-
static balance control, as opposed to the situation in
diabetes, which assist the patient and the physician in
the decision-making (i.e. the blood glucose and glyco-
sylated hemoglobin), the approach of patient education
in HF gained importance also in the current ESC guide-
lines for heart failure (HF), and has been implemented
in the discharge management after acute heart failure
(AHF) [2, 3]. However, we are lacking data on the
efficacy of patient education on endpoints of HF (i.e.
rehospitalization, mortality). This issue may be of im-
portance, since several telemedicine approaches have
not consistently confirmed improvement of prognosis
for HF [4, 5]. Hence, the manuscript by Musekamp et
al., is among the first studies providing important evi-
dence on this issue [1].
In HF, the guide for adjusting drug doses and for de-
ciding changes in therapeutic program includes a varied
constellation of clinical signs and symptoms (dyspnea,
orthopnea, pulmonary rales, nycturia, peripheral edema,
jugular venous distention, hepato-jugular reflux). They
corroborate and complement the valuable information
arising from repeated measurements of body weight,
urine output and serum natriuretic peptide, along with
echocardiographic assessment, in particular the changes
over time in left ventricular ejection fraction (LVEF)
and/or expiratory inferior vena cava diameter, as well as
the alterations in left ventricular global longitudinal
strain using speckle tracking technique. In CHF home
management, the recommended approach is not simply
based on diagnosis and therapy, but it is also an educa-
tional approach involving the patient, as well as the pa-
tient’s family [6]. It is important to remember that one
of the main reasons of fulfillment and satisfaction for a
patient is the achievement of a condition of fair auton-
omy regarding his usual daily activities and engagements
in social life.
The relationship between the perception of a satisfac-
tory degree of autonomy and the improvement of
depressive symptoms in the CHF patient is underlined
by Musekamp et al. [1]. Considerable frustration and
discouragement may arise from the inability to perform
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normal activities of daily living, such as washing, dress-
ing, going upstairs or driving the car. However, before
soliciting training programs trying to retrieve these
skills, it would be important to weigh the pros and
cons, in particular to consider the risks related to the
execution of relatively complex tasks that may put at
further risk the patient’s health, or cause embittering
disillusionment [7, 8]. There is growing transnational
interest in education and self-management programs
for patients with chronic illnesses [9, 10]. Today, a large
repertoire of organizations including hospitals and
community-based facilities are actively engaged in pro-
grams providing theoretical and practical bases for HF
patient’s education and rehabilitation. In particular, the
programs include techniques to decrease symptoms, to
successfully antagonize distress, and to improve coping.
The ultimate scheduled outcome for individuals attend-
ing these programs is improvement of the quality of
life. Patient empowerment and self-management have
also been found to be key intermediate outcomes.
Among the studies that deal with the topic of the
empowerment of CHF patients, the one by Musekamp
et al. [1] provides numerous relevant insights concern-
ing rehabilitation practice. In particular, as regards
self-reported self-management skills measured at the
end of rehabilitation stage (duration 3 weeks), this
variable predicted long-term improvement (after a 12-
month follow-up) in physical quality of life. Moreover,
the same variable predicted intermediate – term
improvement in mental quality of life. Surprisingly,
self-reported self-management skills after 3 weeks of
rehabilitation were not able to predict neither inter-
mediate nor long term changes in depressive symp-
toms. Conversely, self-reported self-management skills
measured after a six-month follow-up were associated
with favorable changes in quality of life and depressive
symptoms estimated after 12 months.
Based on these findings, one would infer that, follow-
ing a program of patient empowerment and functional
rehabilitation specifically projected for CHF patients,
an improvement in physical and mental quality of life
may be achieved more rapidly compared to the target
of earning an effective relief from depressive symptoms.
Therefore, the educational and psychological support of
dedicated professionals (specialized nurses, psycholo-
gists, sociologists) should also be continued beyond the
term of the ordinary residential rehabilitation period.
All efforts should be made to provide the patient with
an adequate educational support. For example, it would
be very valuable the choice to enable the patient to
understand the importance of practicing regular inter-
national normalized ratio (INR) measurements for pa-
tients under phenprocoumon oral anticoagulation.
Additionally, the knowledge to independently perform
adjustment of diuretics may be advantageous [11]. Simi-
larly, it would be a wise initiative to inform the patient
about the sometimes deleterious but well treatable comor-
bidities (from anemia to osteoporosis until prostatic
hypertrophy), or the decision to enable him to recognize
an incipient state of hemodynamic congestion based on
weight gain or decrement of urine excretion. Likewise, it
would be an appropriate educational strategy convincing
the patient to comply with the precaution to practice
prophylaxis with influenza vaccination annually, and to in-
form him about the risks related to prolonged immobility
in case of bone fractures or sural thrombophlebitis [2].
The increased awareness of possible disturbances and
workable remedies can elicit a sense of greater peace of
mind, which in turn could aid the patient to better
accept his condition of disability without becoming a
victim of the anxiety and depression. The neutral re-
sults of escitalopram treatment of depressive CHF pa-
tients in the randomized controlled MOOD-HF trial [7]
gave rise to the hypothesis that comorbidities such as
depression, which undoubtedly contribute to outcome
in HF, are not necessarily responsive to the standard
treatment as the respective comorbidities per se. This
notion is supported by the significant “antidepressive
side effect” of left ventricular assist device (LVAD)
treatment in advanced HF patients, which does not pri-
marily target depression, but directly depressed systolic
LV dysfunction [8]. A likewise discrepancy may be also
attributable to the negative results of the SERVE-HF
trial: the fact that adaptive servo-ventilation is helpful
for central sleep apnea per se, does not necessarily
mean that it is of advantage in central sleep apnea in
HF patients [12]. A multimodal approach addressing
comorbidities in HF patients with novel concepts, and
by optimal and specific HF management, including pa-
tient education, may ultimately contribute to substan-
tial improvement of HF prognosis [2]. We still have to
pave a long way of standardization of patient education
and self-management for this goal in HF management,
and should encourage new studies for this rather
neglected field of HF research.
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